Fundraising Fox

Emerald Health Pharmaceuticals

San Diego, US · Founded 2017 · Delaware corporation

Biotech

Founders & leadership

JS
Joachim SchuppChief Medical Officer
EM
Eduardo MunozChief Scientific Officer
JD
James DeMesaPresident, Chief Executive Officer and Director
AR
Alain RollandChief Operating Officer
LS
Lisa SanfordChief Financial Officer

Board

JL
James L. HeppellBoard director
GA
Gaetano A. MorelloBoard director
PD
Punit DhillonBoard director

Reported raises · per SEC filings

Form D private placements

$3.3M disclosed across 4 rounds · 2017–2021

▶$300KraisedJul 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Punit DhillonDirector
  • James DeMesaExecutive Officer, Director
  • Lisa SanfordExecutive Officer
  • Eduardo MunozExecutive Officer
  • Alain RollandExecutive Officer
  • James HeppellDirector
  • Joachim SchuppExecutive Officer
  • Nancy CoulsonExecutive Officer
  • Gaetano MorelloDirector
Amount sold
$300K
Minimum investment
$100K
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedApr 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joachim SchuppExecutive Officer
  • Eduardo S. MunozExecutive Officer
  • James L. HeppellDirector
  • James DeMesaExecutive Officer, Director
  • Alain RollandExecutive Officer
  • Lisa SanfordExecutive Officer
  • Gaetano A. MorelloDirector
  • Punit DhillonDirector
Offering amount
$500K
Amount sold
$500K
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJun 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Avtar S. DhillonExecutive Officer, Director
  • James DeMesaExecutive Officer
  • Lisa SanfordExecutive Officer
  • Alain RollandExecutive Officer
  • Punit S. DhillonDirector
  • Eduardo MunozExecutive Officer
  • James L. HepellDirector
  • Gaetano A. MorelloDirector
  • Joachim SchuppExecutive Officer
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1KraisedMar 2017 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jill BroadfootExecutive Officer
  • Punit DhillonDirector
  • Avtar DhillonExecutive Officer, Director
  • Gaetano MorelloDirector
  • Jim HeppellDirector
  • Jim DeMesaExecutive Officer
Offering amount
$1K
Amount sold
$1K
First sale
Mar 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Multiple Sclerosis Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharma, Sanofi, RemeGenbarchart.com · Apr 2026Emerald Health Pharmaceuticals Reaches Settlement with U.S. Securities and Exchange Commissionglobenewswire.com · Oct 2022Emerald Health Pharmaceuticals to Open a New Financing Round Under its Regulation A+ Offeringglobenewswire.com · Dec 2020Emerald Health Pharmaceuticals Renews Regulation A Offering and Provides Mid-Year Corporate Update | Markets Insidermarkets.businessinsider.com · Jul 2020

Frequently asked questions

How much funding has Emerald Health Pharmaceuticals raised?
Emerald Health Pharmaceuticals has disclosed $3.3M raised across 4 rounds.
Where is Emerald Health Pharmaceuticals headquartered?
Emerald Health Pharmaceuticals is headquartered in San Diego, US.